http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6008352-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40a92325286ca98dbffa06d2c67ed064 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-22 |
| filingDate | 1998-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b74a065b5375f93a2dd983d3082b8fb0 |
| publicationDate | 1999-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6008352-A |
| titleOfInvention | 1-(isoquinolin-1-yl)-4-(1-phenylmethyl) piperazines; dopamine receptor subtype specific ligands |
| abstract | Disclosed are compounds useful in treating psychotic disorders such as schizophrenia and other central nervous system diseases, where the compounds have general Formula I: wherein: Ar represents an aryl or heteroaryl group; R1 and R2 independently represent hydrogen, halogen, C1-C6 alkyl, C1-C4 alkoxy, C1-C4 alkylthio, hydroxy, amino, mono- or di(C1-C6)alkyl amino, cyano or trifluoromethyl; and R5 represents hydrogen or C1-C6 alkyl. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10221144-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007244147-A1 |
| priorityDate | 1997-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.